Multisystem Inflammatory Syndrome in Children: A Comprehensive Review Over the Past Five Years

Area of Science:

• Pediatric rheumatology
• Infectious diseases
• Public health

Background:

• The COVID-19 pandemic has been linked to the emergence of Multisystem Inflammatory Syndrome in Children (MIS-C).
• MIS-C represents a significant post-infectious complication affecting children.
• Understanding MIS-C is crucial for managing pediatric health during and after viral outbreaks.

Purpose of the Study:

• To provide a comprehensive review of Multisystem Inflammatory Syndrome in Children (MIS-C) over the last five years.
• To analyze the epidemiological factors, pathophysiology, and clinical presentation of MIS-C.
• To summarize current treatment strategies and evaluate short- and long-term patient outcomes.

Main Methods:

• Systematic literature review of studies published in the last five years.
• Analysis of epidemiological data, clinical characteristics, and diagnostic criteria for MIS-C.
• Review of treatment protocols and patient outcome data from various cohorts.

Main Results:

• MIS-C presents with diverse clinical manifestations, often involving multiple organ systems.
• Early recognition and multidisciplinary management are key to improving patient outcomes.
• While most children recover, some experience persistent symptoms or long-term sequelae.

Conclusions:

• MIS-C is a serious condition requiring ongoing research into its long-term effects.
• Effective management strategies for MIS-C have evolved, but further research is needed.
• Continued surveillance and understanding of MIS-C are essential for pediatric public health preparedness.